A total of 138 pathways were obtained from KEGG signaling pathway enrichment analysis, and the significant results are shown in Fig. 5D. Signaling pathways associated with UC therapy mainly include IL-17 signaling pathway, PI3K-Akt signaling pathway and inflammatory bowel disease, etc. Here, IL17A is linked to inflammatory bowel disease.